BENZION FRIEDMAN - 18 May 2017 Form 4 Insider Report for Cell Source, Inc. (CLCS)

Role
Director, 10%+ Owner
Signature
/s/ Benzion Friedman
Issuer symbol
CLCS
Transactions as of
18 May 2017
Net transactions value
+$482,472
Form type
4
Filing time
10 Jun 2021, 13:50:47 UTC
Next filing
07 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLCS Common Stock Other $4,050 +5,400 +0.12% $0.7500* 4,388,744 04 Dec 2017 See footnote F1, F2
transaction CLCS Common Stock Other $5,004 +6,672 +0.15% $0.7500* 4,395,416 21 Aug 2018 See footnote F1, F2
transaction CLCS Common Stock Other $4,083 +5,444 +0.12% $0.7500* 4,400,860 31 Dec 2018 See footnote F1, F2
transaction CLCS Common Stock Other $4,017 +5,356 +0.12% $0.7500* 4,406,216 26 Jun 2019 See footnote F1, F2
transaction CLCS Common Stock Other $19,256 +25,675 +0.58% $0.7500 4,431,891 31 Dec 2019 See footnote F1, F2
transaction CLCS Common Stock Other $14,660 +19,547 +0.44% $0.7500 4,451,438 30 Jun 2020 See footnote F1, F2
transaction CLCS Common Stock Other $14,754 +19,672 +0.44% $0.7500 4,471,200 29 Dec 2020 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLCS Series A Convertible Preferred Stock Award $180,000 +12,000 +38% $15.00* 43,553 26 Jul 2017 Common Stock 120,000 $0.7500 See footnote F2, F3, F4
transaction CLCS Series A Convertible Preferred Stock Award $236,648 +31,553 $7.50* 31,553 07 May 2019 Common Stock 315,530 $0.7500 See footnote F2, F3
transaction CLCS Director Stock Option (Right to Buy) Award $0 +300,000 $0.000000 300,000 19 Aug 2020 Common Stock 300,000 $0.7500 Direct
transaction CLCS Director Stock Option (Right to Buy) Disposed to Issuer $0 -300,000 -100% $0.000000* 0 20 Aug 2020 Common Stock 300,000 $0.7500 Direct
transaction CLCS Director Stock Option (Right to Buy) Award $0 +300,000 $0.000000 300,000 20 Aug 2020 Common Stock 300,000 $0.7500 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued as payment-in-kind dividend on Series A Convertible Preferred Stock.
F2 Owned by a company wholly owned by the wife of the reporting person.
F3 The Series A Convertible Preferred Stock has no expiration date.
F4 The reporting person was issued 12,000 shares of Series A Convertible Preferred Stock and a note in the principal amount of $180,000 for an aggregate purchase price of $180,000